Quarterly Report • Nov 15, 2021
Quarterly Report
Open in ViewerOpens in native device viewer

Société Anonyme 24, rue Astrid L-1143 Luxembourg R.C.S. B 156.864
| Principal Activities | 1 |
|---|---|
| Strategy Implementation | 1 |
| Impact of the Coronavirus COVID-19 | 1 |
| Financial and Operational Results | 2 |
| Subsequent Events | 2 |
| Business and Financial Risks | 2 |
| Corporate Governance | 4 |
| Statement of the Board of Directors and management's responsibility for the | 8 |
|---|---|
| preparation and approval of the interim condensed consolidated financial statements |
| Unaudited Interim Condensed Consolidated Financial Statements | |
|---|---|
| Unaudited Interim Condensed Consolidated Statement of Financial Position | 9 |
| Unaudited Interim Condensed Consolidated Statement of Comprehensive Income | 10 |
| Unaudited Interim Condensed Consolidated Statement of Cash Flows | 11 |
| Unaudited Interim Condensed Consolidated Statement of Changes in Equity | 12 |
Notes to the Unaudited Interim Condensed Consolidated Financial Statements 13-19
KSG Agro S.A., separately referred to as "KSG Agro" or the "Company" and together with its subsidiaries referred to as the "Group", remains among the largest vertically integrated agricultural groups in the Dnipropetrovsk region of Ukraine, present in all major sectors of the agricultural market, including production, storage, processing and sale of agricultural products. Its key operating activities are breeding of pigs, processing of pork and production of wheat and sunflower.
In the nine months of 2021, management have focused their efforts on improving the Group's key financial ratios, specifically its negative net current assets and negative shareholders' equity.
During the year 2020, the Group already managed to increase its net current assets from a negative USD 23.5 million as at 1 January 2020 to a negative USD 6.3 million as at 31 December 2020 and plans to complete the second phase by the end of 2021, thereby bringing net current assets to a positive value.
As at 30 September 2021, the total balance of 'other financial liabilities' as at 31 December 2020 has also decreased. It was mainly settled through disposal of several subsidiaries, as disclosed in detail in Note 15 to the interim condensed consolidated financial statements.
Since the disposed subsidiaries had negative equity, their disposal helped to increase the consolidated 'equity attributable to owners of the parent' from a negative USD 6.2 million as at 31 December 2020 to a positive value as at 30 September 2021.
Improvements in the Group's net current assets and working capital are as follows:
| in USD million | 30 September 2021 |
31 December 2020 |
|
|---|---|---|---|
| Current Assets minus Current Liabilities | (0.1) | (6.3) | |
| less: Other financial assets | (1.1) | (1.1) | |
| less: Other financial liabilities - current | 7.3 | 8.5 | |
| Adjusted Working Capital | 6.1 | 1.1 |
In assessing day-to-day performance of the business, management excludes 'other financial assets' and 'other financial liabilities', as those mostly comprise old non-trade balances subject to restructuring, and analyses the change in the resultant 'adjusted working capital'. Based on management's assessment, the adjusted working capital at the date these financial statements are being issued is positive.
In 2021, the Group started the project to gradually renew its sow population in Ukraine to increase the birth rate of piglets. For this purpose, the Group is working with Genesus, a Canadian genetics company. During the nine months ended 30 September 2021, the Group already received the first batch of sows from Genesus.
The Board of Directors and management have concluded that there was no significant impact on the Group's profitability position to date from the effects of the coronavirus pandemic. The event is not expected to have a material impact on business operations in future periods. Management's analysis of the factors is provided in the last annual consolidated financial statements.
Financial results of the Group's operations for the nine months ended 30 September 2021 and 2020 derived from the consolidated financial statements were as follows:
| In thousands of US dollars | Nine months 2021 |
Nine months 2020 |
Change, % |
|---|---|---|---|
| Revenue | 20,940 | 14,666 | 43% |
| Gain/(loss) on biological transformation, net | 4,515 | 5,961 | (24)% |
| Cost of sales | (18,154) | (13,861) | 31% |
| Gross profit | 7,301 | 6,766 | 8% |
| Selling, general and administrative expenses | (1,154) | (1,211) | (5)% |
| Operating profit | 6,147 | 5,555 | 11% |
| Finance income | 5 | 1,540 | (99)% |
| Finance expenses | (1,568) | (1,511) | 4% |
| Gain/(loss) on foreign currency exchange, net | 1,200 | (1,897) | (163)% |
| Gain on disposal of subsidiaries | 11,577 | (2,610) | (544)% |
| Other gains and losses | (73) | 3,690 | (102)% |
| Profit before tax | 17,288 | 4,767 | 263% |
| Income tax expense | (4) | - | 100% |
| Profit for the period | 17,284 | 4,767 | 263% |
| Operating profit | 6,147 | 5,555 | 11% |
| Depreciation and amortisation | 1,204 | 1,100 | 9% |
| EBITDA | 7,351 | 6,655 | 10% |
Details by segment are disclosed in Note 13 to the interim condensed consolidated financial statements.
All significant events that occurred after the end of the reporting period are described in Note 18 to the interim condensed consolidated financial statements.
The Group takes on exposure to credit risk, which is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. Exposure to credit risk arises as a result of the Group's sales of products on credit terms and other transactions with counterparties giving rise to financial assets.
The Group is exposed to the concentration of credit risk. Management monitors and discloses concentrations of credit risk by obtaining monthly reports with exposures to customers with individually material balances.
The Group takes an exposure to market risks. Market risks arise from open positions in (a) foreign currencies, (b) interest bearing assets and liabilities, all of which are exposed to general and specific market movements. The Group does not have significant interest-bearing financial assets, while the Group's bank and other loans are interest-bearing.
The sensitivities to market risks disclosed below are based on a change in one factor while holding all other factors constant. In practice this is unlikely to occur and changes in some of the factors may be correlated – for example, changes in interest rate and changes in foreign currency rates.
Risk of changes in interest rates is generally related to interest-bearing loans. Loans issued at variable rates expose the borrower to the 'cash flow' interest rate risk, while loans issued at fixed rates expose the borrower to the 'fair value' interest rate risk.
Starting from the fist quarter of 2021, in order to mitigate the associated currency risk, management have arranged for the change in currency of the loans from TASCOMBANK to the Group's functional currency at the cost of switching from a fixed interest rate to a variable rate. The annualised rate on these loans for 2021 is not expected to be higher than 12.5% while the average of fixed rates on the same loans in 2020 was around 10%. Refer to Note 11 for details.
Foreign currency exchange risk arises when future commercial transactions or recognised assets or liabilities are denominated in a currency that is not the entity's functional currency. During the year ended 31 December 2020, the Group has been most susceptible to the currency risk with regard to its bank loans and intercompany loans.
As at 31 December 2020, the total amount of foreign-currency bank loans was USD 12,201 thousand. To mitigate the currency risk, management have arranged for the change in currency of the loans from TASCOMBANK to the Group's functional currency at the cost of switching from a fixed interest rate to a variable rate. Refer to Note 11 for details.
Liquidity risk is the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities. Liquidity risk is managed by monitoring monthly rolling forecasts of the Group's cash flows. The Group seeks to maintain a stable funding base mostly through proper management of its working capital and using short-term bank and company loans to cover the cash gaps.
During the year 2020, the Group already managed to increase its net current assets from a negative USD 23.5 million as at 1 January 2020 to a negative USD 6.3 million as at 31 December 2020 and plans to complete the second phase by the end of 2021, thereby bringing net current assets to a positive value.
As at 30 September 2021, the total balance of 'other financial liabilities' as at 31 December 2020 has also decreased. It was mainly settled through disposal of several subsidiaries, as disclosed in detail in Note 15 to the interim condensed consolidated financial statements.
Improvements in the Group's net current assets and working capital are as follows:
| in USD million | 30 September 2021 |
31 December 2020 |
|---|---|---|
| Current Assets minus Current Liabilities | (0.1) | (6.3) |
| less: Other financial assets | (1.1) | (1.1) |
| less: Other financial liabilities - current | 7.3 | 8.5 |
| Adjusted Working Capital | 6.1 | 1.1 |
In assessing day-to-day performance of the business, management excludes 'other financial assets' and 'other financial liabilities', as those mostly comprise old non-trade balances subject to restructuring, and analyses the change in the resultant 'adjusted working capital'. Based on management's assessment, the adjusted working capital at the date these financial statements are being issued is positive.
The Group's objectives when managing capital are to safeguard the Group's ability to continue as a going concern in order to provide returns for shareholders and benefits for other stakeholders as well as to provide financing of its operating requirements, capital expenditures and Group's development strategy. The Group's capital management policies aim to ensure and maintain an optimal capital structure to reduce the overall cost of capital and flexibility relating to Group's access to capital markets.
Management monitors on a regular basis the Group's capital structure and may adjust its capital management policies and targets following changes in its operating environment, market sentiment or its development strategy. Management believes it is responding appropriately to all the risks identified in order to support the sustainability of the Group's business in the current circumstances.
The Board of Directors (the "Board") observes the majority of Warsaw Stock Exchange corporate governance rules included in the "Code of Best Practice for WSE Listed Companies" in the form and to the extent determined by the Resolution No. 19/1307/2012 of the Exchange Supervisory Board dated 21 November 2012. Code of Best Practice for WSE Listed Companies is available at the official website of the Warsaw Stock Exchange
The Board of Directors consists of five members, three of each hold an executive role (Directors A), and two directors are non executive ones (Directors B)
Mr. Sergiy Kasianov, Chairman of the Board of Directors, has a significant indirect holding of securities in the Company. No other person has a significant direct or indirect holding of securities in the Company. No person has any special rights of control over the Company's share capital.
There are no restrictions on voting rights.
With regard to the appointment and replacement of Directors, its Articles of Association (hereinafter referred to as the "Articles of Association") and Luxembourg Law comprising the Companies Law 1915 govern the Company. A general meeting of the shareholders under the quorum may amend the Articles of Association from time to time and majority requirement provided for by the Law of 10 August 1915 On Commercial Companies in Luxembourg, as amended.
The Board is responsible for managing the business affairs of the Company within the clauses of the Articles of Association. The Directors may only act at duly convened meetings of the Board of Directors or by written consent in accordance with article 9 of Articles of Association.
Articles of Association and national laws and regulation govern the operation of the shareholders meetings and their key powers, description of their rights.
Transfer of shares is governed by Articles of Association of the Company.
In this regard the Company is governed by Article 9 of the Articles of Association.
Mr. Sergiy Kasianov has been appointed as Chairman of the Board of Directors.
The Board of Directors shall meet upon call by the Chairman, or any two Directors at the place and time indicated in the notice of meeting, the person(s) convening the meeting setting the agenda.
Written notice of any meeting of the Board of Directors shall be given to all Directors at least five (5) calendar days in advance of the hour set for such meeting, except in circumstances of emergency where 24 hours prior notice shall suffice which shall duly set out the reason for the urgency.
The board of Directors may act validly and validly adopt resolutions if approved by the majority of Directors including at least one class A and one class B Director at least a majority of the Directors are present or represented at a meeting.
The audit committee is composed of three members and is in charge of overseeing financial reporting and disclosure.
The Company's management is responsible for establishing and maintaining adequate controls over financial reporting process for KSG Agro S.A., which include the appropriate level of Board of Directors' involvement.
KSG Agro S.A. maintains an effective internal control structure. It consists, in particular, of organizational arrangements with clearly defined lines of responsibility and delegation of authority, and comprehensive systems and control procedures. An important element of the control environment is an ongoing internal audit program. KSG Agro S.A. system also contains monitoring mechanisms, and actions taken to correct deficiencies if they identified.
To assure the effective administration of internal controls, KSG Agro S.A. carefully selects employees, develops and disseminates oral and written policies and procedures, provides appropriate communication channels and fosters an environment conducive to the effective functioning of controls.
The Company's internal control over financial reporting includes those policies and procedures that:
We believe that it is essential for the Company to conduct its business affairs in accordance with the highest ethical standards, as set forth in KSG Agro S.A.
Article 11 a) the structure of their capital, including securities which are not admitted to trading on a regulated market in a Member State, where appropriate with an indication of the different classes of shares and, for each class of shares, the rights and obligations attaching to it and the percentage of total share capital that it represents.
According to article 5.1 of the articles of association of the Company (the Articles), the Company's subscribed share capital amounts to one hundred fifty thousand two hundred United States Dollars (USD 150,200.00) represented by fifteen million twenty thousand (15,020,000) shares having a nominal value of one Cent (USD 0.01) each.
All the issued share capital of the Company is admitted to listing and trading on the main market of the Warsaw Stock Exchange.
On May 23, 2013 The Company bought back thirty-two thousand one hundred and seventy-two (32,172) own shares, representing 0.21% of share capital, that are accounted for as treasury shares.
The shares of the Company are transferred in accordance with customary procedures for the transfer of securities in Book-entry form.
Furthermore, there is no restriction in relation with the transfer of securities pursuant to article 7.5 of the Articles. The sole requirement is that any transfer shall be recorded in the register of shares of the Company.
In accordance with article 7.10 of the Articles, any shareholder, company or individual, who acquires or sells shares, including certificates representing shares of the Company, shall notify to the Company the percentage of the voting rights he/she/it will own pursuant to such acquisition or sale, in case such percentage reaches the thresholds of 5%, 10%, 15%, 20%, 33 1/3%, 50% and 66 2/3% or supersedes or falls under such thresholds. The shareholders shall also notify the Company should the percentage of their respective voting rights reach the above mentioned thresholds or supersede them or fall under such thresholds pursuant to certain events amending the voting rights repartition of the Company.
Those notification requirements apply also to certain situations as listed by article 9 of the law of 11 January 2008 on transparency obligations with respect to the information of companies which securities are listed on a regulated market.
The distribution of shares of the Company as at the reporting date is as follows:
OLBIS Investments LTD S.A. holds eight million seven hundred and five thousand five hundred (8,705,500) shares, representing 57.96% of the issued share capital of the Company.
KSG Agro S.A holds thirty-two thousand one hundred seventy-two (32,172) shares, representing 0.21% of the issued share capital of the Company.
In free float there are six million two hundred and eighty-two thousand three hundred twenty-eight (6,282,328) shares, representing 41.83% of the issued share capital of the Company.
The distribution of shares during the reporting period has changed. See Note 17 to the interim condensed consolidated financial statements for details.
There are no special control rights.
There is no employee share scheme.
Article 11 f) any restrictions on voting rights, such as limitations of the voting rights of holders of a given percentage or number of votes, deadlines for exercising voting rights, or systems whereby, with the company's cooperation, the financial rights attaching to securities are separated from the holding of securities.
Pursuant to article 7.10 of the Articles, if a shareholder breaches the thresholds mentioned in point b) and fails to notify the Company within the period of four (4) listing days, as stated therein, the exercise of voting rights attached to the new participation exceeding the relevant threshold will be suspended.
To the best of our knowledge there are no such agreements.
Pursuant to article 8 of the Articles, the directors of the Company (the Directors or the Board, as applicable) are to be appointed by the general meeting of the shareholders of the Company (the General Meeting) for a period not exceeding six (6) years and until their successors are elected. Moreover, the decision to suspend or dismiss a Director must be adopted by the General Meeting with a majority of more than one-half (1/2) of all voting rights present or represented. When a legal person is appointed as Director, the legal entity must designate a permanent representative (représentant permanent) in accordance with article 51bis of the Law of 10 August 1915 On Commercial Companies, as amended (the Company Law).
In accordance with article 20 of the Articles, the Articles may be amended from time to time by a General Meeting under the quorum and majority requirements provided for by the Company Law.
With respect to the acquisition of own shares, article 6 of the Articles establishes that the Company may acquire its own Shares to the extent permitted by law. To the extent permitted by Luxembourg law, the Board is irrevocably authorized and empowered to take any and all steps to execute any and all documents to do and perform any and all acts for and in the name and on behalf of the Company which may be necessary or advisable in order to effectuate the acquisition of the shares and the accomplishment and completion of all related actions.
According to article 11.2 of the Articles, the Board is vested with the broadest powers to perform all acts of administration and disposition in the Company's interests and within the objectives and purposes of the Company. All powers not expressly reserved by law or by the Articles to the General Meeting fall within the competence of the Board.
Article 11 j) any significant agreements to which the company is a party and which take effect, alter or terminate upon a change of control of the company following a takeover bid, and the effects thereof, except where their nature is such that their disclosure would be seriously prejudicial to the company; this exception shall not apply where the company is specifically obliged to disclose such information on the basis of other legal requirements.
To the extent of our knowledge there are no such agreements.
Article 11 k) any agreements between the company and its board members or employees providing for compensation if they resign or are made redundant without valid reason or if their employment ceases because of a takeover bid.
To the extent of our knowledge there are no such agreements.
This management report for the nine months ended 30 September 2021 was approved for issue on 15 November 2021.
________________________
А.V. Skorokhod (Chief Executive Officer)
________________________
Y.V. Kyselova (Chief Financial Officer)
The following statement is made with a view to clarify responsibilities of management and Board of Directors in relation to the interim condensed consolidated financial statements of KSG AGRO S.A. and its subsidiaries (further – the Group).
The Board of Directors and management of the Group are responsible for preparation of the interim condensed consolidated financial statements of the Group as at 30 September 2021 and for the nine months then ended in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union.
In preparing the interim condensed consolidated financial statements, the Board of Directors and management are responsible for:
The Board of Directors and management are also responsible for:
In accordance with Article 4 (2) (c) of the Law of Luxembourg of 11 January 2008 on the harmonisation of transparency requirements in relation to information about issuers whose securities are admitted to trading on a regulated market, we declare that, to the best of our knowledge, the interim condensed consolidated financial statements for the nine months ended 30 September 2021, prepared in accordance with International Financial Reporting Standards as adopted by the European Union, give a true and fair view of the financial position, financial performance and cash flows of KSG Agro S.A. and its subsidiaries included in the consolidation taken as a whole.
In addition, the interim management report includes a fair review of the performance, position, progress and development prospects of KSG Agro S.A. and its subsidiaries included in the consolidation taken as a whole, together with a description of the principal risks and uncertainties that they face.
These interim condensed consolidated financial statements as at 30 September 2021 and for the nine months then ended were approved for issue on 15 November 2021.
STATEMENT OF THE BOARD ________________________
А.V. Skorokhod (Chief Executive Officer)
________________________
Y.V. Kyselova (Chief Financial Officer)
as at 30 September 2021
| 30 September | 31 December | ||
|---|---|---|---|
| In thousands of US dollars | Note | 2021 | 2020 |
| ASSETS | |||
| Non-current assets | |||
| Property, plant and equipment | 15,435 | 15,568 | |
| Long-term biological assets | 7 | 30,739 | 27,816 |
| Long-term investments | 16 | 2,352 | - |
| Right-of-use assets | 752 | 716 | |
| Total non-current assets | 49,278 | 44,100 | |
| Current assets | |||
| Current biological assets | 7 | 9,935 | 6,306 |
| Inventories and agricultural produce | 8 | 6,257 | 7,952 |
| Trade receivables | 9 | 3,948 | 1,890 |
| Other financial assets | 10 | 1,162 | 1,132 |
| Taxes recoverable | 723 | 854 | |
| Prepaid assets | 626 | 610 | |
| Cash and cash equivalents | 1,985 | 108 | |
| Total current assets | 24,636 | 18,852 | |
| TOTAL ASSETS | 73,914 | 62,952 | |
| EQUITY | |||
| Share capital | 150 | 150 | |
| Share premium | 37,366 | 37,366 | |
| Treasury shares | (112) | (112) | |
| Retained earnings | (27,686) | (43,156) | |
| Currency translation reserve | (4,292) | (2,074) | |
| Equity attributable to the owners of the Company | 5,426 | (7,826) | |
| Non-controlling interests | 14,529 | 13,208 | |
| TOTAL EQUITY | 19,955 | 5,382 | |
| LIABILITIES | |||
| Non-current liabilities | |||
| Bank and other loans | 11 | 27,185 | 24,520 |
| Other financial liabilities | 12 | - | 5,941 |
| Lease liabilities | 2,039 | 1,918 | |
| Total non-current liabilities | 29,224 | 32,379 | |
| Current liabilities | |||
| Trade payables | 10,154 | 10,118 | |
| Other financial liabilities | 12 | 7,362 | 8,514 |
| Bank and other loans | 11 | 2,513 | 2,878 |
| Advances from customers | 3,862 | 2,796 | |
| Lease liabilities | 683 | 697 | |
| Tax liabilities | 161 | 188 | |
| Total current liabilities | 24,735 | 25,191 | |
| TOTAL LIABILITIES | 53,959 | 57,570 | |
| TOTAL LIABILITIES AND EQUITY | 73,914 | 62,952 |
Approved for issue and signed on behalf of the Board of Directors on 15 November 2021.
________________________ А.V. Skorokhod
BALANCE SHEET
(Chief Executive Officer)
________________________
Y.V. Kyselova (Chief Financial Officer)
The accompanying notes are an integral part of these consolidated financial statements
for the nine months ended 30 September 2021
| In thousands of US dollars | Note | Nine months 2021 |
Nine months 2020 |
|---|---|---|---|
| Revenue | 13 | 20,940 | 14,666 |
| Gain/(loss) on biological transformation, net | 13 | 4,515 | 5,961 |
| Cost of sales | 13 | (18,154) | (13,861) |
| Gross profit | 7,301 | 6,766 | |
| Selling, general and administrative expenses | (1,154) | (1,211) | |
| Operating profit | 6,147 | 5,555 | |
| Finance income | 5 | 1,540 | |
| Finance expenses | (1,568) | (1,511) | |
| Gain/(loss) on foreign currency exchange, net | 1,200 | (1,897) | |
| Gain on disposal of subsidiaries | 15 | 11,577 | (2,610) |
| Other gains and losses | (73) | 3,690 | |
| Profit before tax | 17,288 | 4,767 | |
| Income tax expense | (4) | - | |
| Profit for the period | 17,284 | 4,767 | |
| Other comprehensive income/(loss) | 700 | (3,207) | |
| Currency translation differences | 17,984 | 1,560 | |
| Total comprehensive income/(loss) | |||
| Profit attributable to: | |||
| Owners of the Company | 15,470 | 6,032 | |
| Non-controlling interest | 1,814 | (1,265) | |
| Profit for the period | 17,284 | 4,767 | |
| Total comprehensive income/(loss) attributable to: | |||
| Owners of the Company | 16,663 | 5,734 | |
| Non-controlling interests | 1,321 | (4,174) | |
| Total comprehensive income/(loss) | 17,984 | 1,560 | |
| Earnings per share | |||
| Weighted average number of common shares outstanding, thousand | 15,020 | 15,020 | |
| Basic and diluted earnings per share, USD | 1.03 | 0.40 |
Approved for issue and signed on behalf of the Board of Directors on 15 November 2021.
________________________
А.V. Skorokhod (Chief Executive Officer)
INCOME STATEMENT
________________________
Y.V. Kyselova (Chief Financial Officer)
for the nine months ended 30 September 2021
| In thousands of US dollars | Note | Nine months 2021 |
Nine months 2020 |
|---|---|---|---|
| Cash flow from operating activities | |||
| Profit before tax | 17,288 | 4,767 | |
| Adjustments for: | |||
| Depreciation and amortisation | 1,204 | 1,100 | |
| (Gain)/loss on biological transformation, net | (4,515) | (5,961) | |
| (Gain)/loss on disposal of subsidiaries | 15 | (11,577) | 2,610 |
| Finance expenses, net | 1,563 | (29) | |
| Exchange differences | (3,510) | 3,912 | |
| Other gains and losses | 73 | (3,770) | |
| Operating cash flow before working capital changes | 526 | 2,629 | |
| Change in trade receivables and other financial assets | (3,116) | (2,678) | |
| Change in current biological assets | 5,619 | (3,536) | |
| Change in inventories and agricultural produce | (2,458) | 1,635 | |
| Change in tax assets and liabilities | 143 | (1,194) | |
| Change in trade payables and other financial liabilities | 4,235 | 3,703 | |
| Cash generated from operations | 4,949 | 559 | |
| Interest paid on loans and leases | (1,240) | (997) | |
| Income tax paid | (6) | (13) | |
| Cash generated from / (used in) operating activities | 3,703 | (451) | |
| Cash flow from investing activities | |||
| Payments for acquisition of property, plant and equipment | (872) | (1,044) | |
| Payments for acquisition of sows | 7 | (223) | - |
| Investments into long-term projects | 16 | (2,265) | - |
| Disposal of subsidiaries, net of cash disposed | 15 | - | - |
| Cash generated from / (used in) investing activities | (3,360) | (1,044) | |
| Cash flow from financing activities | |||
| Proceeds from bank and other loans | 3,237 | 8,808 | |
| Repayment of bank and other loans | (1,774) | (7,383) | |
| Repayment of leases | - | - | |
| Cash generated from / (used in) financing activities | 1,463 | 1,425 | |
| Net (decrease) / increase in cash and cash equivalents | 1,806 | (70) | |
| Cash and cash equivalents at the beginning of the period | 108 | 299 | |
| Effect of exchange rate differences on cash and cash equivalents | 71 | (42) | |
| Cash and cash equivalents at the end of the period | 1,985 | 187 |
Approved for issue and signed on behalf of the Board of Directors on 15 November 2021.
________________________
CASH FLOW
А.V. Skorokhod (Chief Executive Officer)
________________________
Y.V. Kyselova (Chief Financial Officer)
for the nine months ended 30 September 2021
| Attributable to owners of the Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| In thousands of US dollars | Note | Share capital |
Share premium |
Treasury shares |
Currency translation reserve |
Retained earnings |
Total attributable to owners of the Company |
Non controlling interest |
Total equity |
| Balance as at 1 January 2020 | 150 | 37,366 | (112) | (5,714) | (37,901) | (6,211) | 17,533 | 11,322 | |
| Profit for the period | - | - | - | - | 6,032 | 6,032 | (1,265) | 4,767 | |
| Other comprehensive income/(loss) | - | - | - | (298) | - | (298) | (2,909) | (3,207) | |
| Total comprehensive income/(loss) | - | - | - | (298) | 6,032 | 5,734 | (4,174) | 1,560 | |
| Balance as at 30 September 2020 |
150 | 37,366 | (112) | (6,012) | (31,869) | (477) | 13,359 | 12,882 | |
| Balance as at 1 January 2021 | 150 | 37,366 | (112) | (2,074) | (43,156) | (7,826) | 13,208 | 5,382 | |
| Profit for the period | - | - | - | - | 15,470 | 15,470 | 1,814 | 17,284 | |
| Other comprehensive income/(loss) | - | - | - | 1,193 | - | 1,193 | (493) | 700 | |
| Total comprehensive income/(loss) | - | - | - | 1,193 | 15,470 | 16,663 | 1,321 | 17,984 | |
| Disposal of subsidiaries | 15 | - | - | - | (3,411) | - | (3,411) | - | (3,411) |
| Balance as at 30 September 2021 |
150 | 37,366 | (112) | (4,292) | (27,686) | 5,426 | 14,529 | 19,955 |
Approved for issue and signed on behalf of the Board of Directors on 15 November 2021.
________________________
EQUITY
А.V. Skorokhod (Chief Executive Officer)
________________________
Y.V. Kyselova (Chief Financial Officer)
The accompanying notes are an integral part of these interim condensed consolidated financial statements
(All amounts in thousands of US dollars, unless otherwise stated)
KSG Agro S.A. (the "Company") was incorporated under the name Borquest S.A. on 16 November 2010 as a "Société Anonyme" under Luxembourg Company Law for an unlimited period. On 08 March 2011 the Company's name was changed to KSG Agro S.A.
The registered office of the Company is at 24, rue Astrid, L-1143 Luxembourg and the Company number with the Registre de Commerce is B 156 864.
The Company and its subsidiaries (together referred to as the "Group") produces, stores, processes and sells agricultural products, mostly crops, pork and pigs in live weight, and its business activities are conducted mainly in Ukraine.
The Company's immediate parent is OLBIS Investments LTD. S.A., registered in Panama, and the ultimate controlling party is Mr. Sergiy Kasianov. OLBIS Investments LTD. S.A. holds 57.96% of the issued share capital of the Company, 0.21% of shares are treasury shares and the remaining 41.83% are free float shares listed on the Warsaw Stock Exchange. As at 31 December 2020, the stake of OLBIS Investments LTD. S.A. was 64.62%, but it decreased due to the sale of 1 million shares in August 2021 (Note 17).
Principal activities of the entities forming the Group and the Company's effective ownership interest in these entities as at 30 September 2021 and 31 December 2020 were as follows:
| Country of | Effective ownership ratio, % | ||||
|---|---|---|---|---|---|
| Entity | Principal activity | registration | 30 September 2021 |
31 December 2020 |
|
| KSG Agro S.A. | Holding company | Luxembourg | |||
| KSG Agricultural and Industrial Holding LTD |
Subholding company | Cyprus | 100% | 100% | |
| KSG Dnipro LLC | Crop farming | Ukraine | 100% | 100% | |
| Agro Golden LLC | Crop farming | Ukraine | 100% | 100% | |
| Souz-3 LLC (Note 15) | Disposed | Ukraine | - | 100% | |
| Agro-Trade House Dniprovsky LLC | Crop farming | Ukraine | 100% | 100% | |
| SPE Promvok LLC | Crop farming | Ukraine | 100% | 100% | |
| Scorpio Agro LLC | Crop farming | Ukraine | 100% | 100% | |
| Agrofirm Vesna LLC (Note 15) | Disposed | Ukraine | - | 100% | |
| Trade House of the Ukrainian Agroindustrial Holding LLC (Note 15) |
Disposed | Ukraine | - | 100% | |
| Hlebna Liga LLC | Dormant | Ukraine | 100% | 100% | |
| Enterprise #2 of Ukrainian Agricultural and Industrial Holding LLC |
Dormant | Ukraine | 100% | 100% | |
| KSG Trade House LTD (Note 15) | Disposed | Ukraine | - | 100% | |
| Askoninteks LLC (Note 15) | Disposed | Ukraine | - | 100% | |
| Abbondanza SA | Trade of agricultural products |
Switzerland | 50% | 50% | |
| Parisifia LTD | Intermediate holding company |
Cyprus | 50% | 50% | |
| Agroplaza LLC | Intermediate holding company |
Ukraine | 50% | 50% | |
| Kolosyste LLC | Dormant | Ukraine | 50% | 50% | |
| Stepove LLC | Dormant | Ukraine | 50% | 50% | |
| Dzherelo LLC | Dormant | Ukraine | 50% | 50% | |
| Rantye LLC | Pig breeding | Ukraine | 50% | 50% | |
| Strong-Invest LLC | Pig breeding | Ukraine | 50% | 50% | |
| Modern Agricultural Investments LLC | Pig breeding | Ukraine | 50% | - | |
| Pererobnyk PE LLC (i) | Dormant | Ukraine | 25% | 25% | |
| Ukrzernoprom - Prudy LLC (ii) | Ukraine | 50% | 50% | ||
| Ukrzernoprom - Uyutne LLC (ii) | Dormant, assets are | Ukraine | 50% | 50% | |
| Ukrzernoprom - Kirovske LLC (ii) | on occupied territory | Ukraine | 50% | 50% | |
| Ukrzernoprom - Yelizavetove LLC (ii) | Ukraine | 50% | 50% |
(i) The Group has no operating control over the company and accounts for this investment under the equity method, although it is not separately presented in the consolidated financial statements due to its immateriality.
(ii) Ukrzernoprom entities are located in Crimea and are not consolidated, as the Group has no operating control over them since October 2014. Carrying values of the associated investments had been written down to zero.
The Group consolidates all other subsidiaries, including those where it owns less than 51 per cent of the equity shares. Based on the contractual arrangements between the Group and other investors, the Group has the power to appoint and remove the majority of the board of directors of these subsidiaries. Relevant activities of the subsidiaries are determined by their boards of directors based on simple majority votes. Therefore, management of the Group concluded that the Group has control over the subsidiaries and the subsidiaries are consolidated in these financial statements.
In determining the appropriate basis for preparation of the consolidated financial statements, the Board of Directors and management are required to consider whether the Group can continue in operational existence for the foreseeable future. Financial performance of the Group is naturally dependent upon weather conditions in areas of operation and the wider economic environment of Ukraine. In addition, the Group had to tackle the challenges of low liquidity and the coronavirus.
As discussed in the Group's last annual financial statements, the Board of Directors and management are not aware of any material uncertainties related to events or conditions that may cast significant doubt upon the Group's ability to continue as a going concern.
Based on their analysis of the impact on the Group's business from the operating environment and the ongoing coronavirus pandemic, based on the successful results of loan restructuring and current improvements in key financial ratios of the Group, the Board of Directors and management believe that the Group can continue as a going concern for the next twelve months from the date these financial statements are being issued.
Management have reviewed the following new and amended IFRS Standards and Interpretations and adopted the ones that are effective for annual periods beginning on or after 1 January 2021:
As a result of the review, management conclude that adoption of the above Standards and Interpretations will not have any material effect on the disclosures or on the amounts reported in both current and future periods.
These interim condensed consolidated financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB") and interpretations of IFRS issued by the International Financial Reporting Interpretations Committee ("IFRIC"), and as adopted by the European Union.
Specifically, these financial statements have been prepared in accordance with International Accounting Standard (IAS) 34 "Interim Financial Reporting", and should be read in conjunction with the Group's last annual consolidated financial statements as at and for the year ended 31 December 2020 ('last annual financial statements').
These financial statements are condensed, i.e. they do not include all the information required for a complete set of IFRS financial statements. However, selected explanatory notes are included to explain events and transactions that management deemed significant to an understanding of the changes in the Group's financial position and performance since the last annual financial statements.
The accounting policies applied in these interim financial statements are the same as those applied in the Group's last annual financial statements. Any changes in accounting policies during the interim period are also expected to be reflected in the Group's consolidated financial statements as at and for the year ending 31 December 2021.
The currency of each consolidated entity is the currency of the primary economic environment in which the entity operates. The functional currency for the majority of the consolidated entities is the Ukrainian hryvnia. As the Group's management use USD when monitoring operating results and financial condition of the Group, the presentation currency of these financial statements is USD.
The exchange rates used for translating foreign currency balances were:
| USD | EUR | |
|---|---|---|
| As at 31 December 2020 | 28.2746 | 34.7396 |
| Average for the nine months ended 30 September 2020 | 26.5261 | 29.8292 |
| As at 30 September 2021 | 26.5760 | 30.9810 |
| Average for the nine months ended 30 September 2021 | 27.4866 | 32.9022 |
| As at the date these financial statements are being issued | 26.0927 | 30.2075 |
Management make estimates and assumptions that affect the amounts recognised in the financial statements. Estimates and judgements are continually evaluated and are based on management's experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Management also make certain judgements, apart from those involving estimations, in the process of applying the Group's accounting policies.
The significant judgments made by Management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those that applied to the last annual financial statements.
| 30 September 2021 | 31 December 2020 | |||
|---|---|---|---|---|
| Non-current biological assets (swines) | Units | Amount | Units | Amount |
| Sows (i) | 5,877 | 30,733 | 5,404 | 27,808 |
| Boars | 32 | 6 | 39 | 8 |
| Total non-current biological assets | 30,739 | 27,816 | ||
| Current biological assets (swines) | Units | Amount | Units | Amount |
| Pigs and piglets | 41,131 | 2,599 | 41,416 | 1,904 |
| Current biological assets (crops) (ii) | Hectares | Amount | Hectares | Amount |
| Wheat | - | - | 7,061 | 3,295 |
| Barley | - | - | 1,176 | 565 |
| Rapeseed | - | - | 1,856 | 290 |
| Sunflower | 8,377 | 6,190 | - | - |
| Corn | 1,804 | 553 | - | - |
| Other | 593 | 252 | ||
| Total current biological assets | 9,935 | 6,306 | ||
| Total biological assets | 40,674 | 34,122 |
(i) In 2021, the Group started the project to gradually renew its sow population in Ukraine to increase the birth rate of piglets. For this purpose, the Group is working with Genesus, a Canadian genetics company. During the nine months ended 30 September 2021, the Group already received the first batch of sows from Genesus.
(ii) Volume of crops harvested in 2021 year-to-date (in bunker weight) was as follows:
| Up to 5 November 2021 | Up to 30 September 2021 | |
|---|---|---|
| in tonnes | in tonnes | |
| Wheat | 30,550 | 30,550 |
| Barley | 8,561 | 8,561 |
| Rapeseed | 760 | 760 |
| Sunflower | 19,551 | 10,450 |
| Corn | 7,758 | 186 |
| Total harvest, tonnes | 67,180 | 50,507 |
| 30 September 2021 | 31 December 2020 | |
|---|---|---|
| Agricultural produce | 3,776 | 1,544 |
| Land cultivation and harvesting | 487 | 1,903 |
| Seeds, fertilisers, crop protection products | 1,015 | 1,267 |
| Construction materials | 103 | 1,154 |
| Fodder (raw materials) | 168 | 860 |
| Fodder (processed) | 310 | 142 |
| Fuel | 232 | 758 |
| Goods for resale | 61 | 232 |
| Other | 105 | 92 |
| Total inventories and agricultural produce | 6,257 | 7,952 |
| 30 September 2021 | 31 December 2020 | |
|---|---|---|
| Receivables from customers | 4,816 | 7,482 |
| Less: impairment | (868) | (5,592) |
| Total trade receivables | 3,948 | 1,890 |
| 30 September 2021 | 31 December 2020 | |
|---|---|---|
| Company loans issued | 786 | 3,885 |
| Less: impairment of company loans issued | (9) | (3,039) |
| Other receivables | 452 | 784 |
| Less: impairment of other receivables | (67) | (498) |
| Total other financial assets | 1,162 | 1,132 |
| 30 September 2021 | 31 December 2020 |
|---|---|
| 15,348 | 27,316 |
| 14,350 | 82 |
| 29,698 | 27,398 |
To mitigate the currency risk, the currency of TASCOMBANK loans, which amounted to USD 12,201 thousand as at 31 December 2020, was changed from USD to UAH at the cost of switching from a fixed interest rate to a variable rate. Effective from the fist quarter of 2021, the Group does not have any foreign-currency loans.
(All amounts in thousands of US dollars, unless otherwise stated)
| 30 September 2021 | 31 December 2020 | |
|---|---|---|
| Other payables | 3,820 | 10,268 |
| Short-term promissory notes issued | 1,998 | 2,344 |
| Company loans received | 1,378 | 1,683 |
| Wages and salaries payable | 166 | 160 |
| Total other financial liabilities | 7,362 | 14,455 |
| Less: non-current portion of other payables | - | (5,941) |
| Total current portion | 7,362 | 8,514 |
Non-current portion of other payables as at 31 December 2020 represents the carrying amount of liabilities assumed with the acquisition of Souz-3 LLC. Details on the acquisition of Souz-3 are provided in the last annual financial statements.
The decrease in other payables during the nine months ended 30 September 2021 is largely attributable to the disposal of Souz-3 LLC and four other subsidiaries (Note 15).
Information about operating segments for the nine months ended 30 September 2021 is as follows:
| Crop Farming | Pig Breeding | Other | Total | |
|---|---|---|---|---|
| Revenue, including: | ||||
| - sales of goods | 10,274 | 8,092 | 195 | 18,561 |
| - rendering of services | 1,832 | - | 547 | 2,379 |
| Revenue from external customers | 12,106 | 8,092 | 742 | 20,940 |
| Gain/(loss) on biological transformation, net | 3,797 | 718 | - | 4,515 |
| Cost of sales | (10,530) | (7,339) | (285) | (18,154) |
| Segment profit/(loss) | 5,373 | 1,471 | 457 | 7,301 |
Information about operating segments for the nine months ended 30 September 2020 is as follows:
| Crop Farming | Pig Breeding | Other | Total | |
|---|---|---|---|---|
| Revenue, including: | ||||
| - sales of goods | 4,688 | 7,414 | 354 | 12,456 |
| - rendering of services | 2,172 | - | 38 | 2,210 |
| Revenue from external customers | 6,860 | 7,414 | 392 | 14,666 |
| Gain/(loss) on biological transformation, net | 4,886 | 1,075 | - | 5,961 |
| Cost of sales | (4,967) | (8,070) | (824) | (13,861) |
| Segment profit/(loss) | 6,779 | 419 | (432) | 6,766 |
Crop Farming segment, due to seasonality and implications of relevant reporting standards, in the first half of the year mainly reflects the sales of carried forward agricultural produce and effect of biological assets revaluation, while during the second half of the year it reflects sales of crops and effect of revaluation of agricultural produce harvested during the year. Also, crop farming has seasonal requirements for working capital increase during November-May, to finance land cultivation work. Other segments are not significantly exposed to seasonal fluctuations.
Significant transactions with related parties were as follows:
| Nine months 2021 | Nine months 2020 | ||||
|---|---|---|---|---|---|
| Parent and owners |
Entities under common control |
Parent and owners |
Entities under common control |
||
| Income Sales of pigs and pork Other services |
- - |
3,130 94 |
- - |
2,522 23 |
|
| Expenses Interest expense on loans |
233 | - | 233 | - |
In May 2021, the Group disposed of its subsidiaries Souz-3 LLC, Agrofirm Vesna LLC, Trade House of the Ukrainian Agroindustrial Holding LLC ("Trade House UAIH LLC").
In September 2021, the Group disposed of its subsidiaries KSG Trade House LTD and Askoninteks LLC.
Agrofirm Vesna LLC, Trade House UAIH LLC, KSG Trade House LTD, Askoninteks LLC were all dormant entities.
Effect of these disposals for the nine months ended 30 September 2021 was as follows:
| Souz-3 LLC | Agrofirm Vesna LLC |
Trade House UAIH LLC |
KSG Trade House LTD |
Askoninteks LLC |
TOTAL | |
|---|---|---|---|---|---|---|
| Effective ownership ratio, % | 100% | 100% | 100% | 100% | 100% | |
| Property, plant and equipment | 512 | 71 | 224 | - | - | 807 |
| Current biological assets | 517 | - | - | - | - | 517 |
| Inventories and agricultural produce | 201 | - | - | - | - | 201 |
| Trade receivables | 29 | - | 415 | - | - | 444 |
| Other financial assets | 143 | 616 | 450 | - | - | 1,209 |
| Taxes recoverable | 51 | - | - | - | - | 51 |
| Prepaid assets | - | - | 257 | - | - | 257 |
| Trade payables | (476) | - | (194) | - | - | (670) |
| Other financial liabilities | (7,785) | (1,766) | (972) | (410) | - | (10,933) |
| Tax liabilities | (49) | - | - | - | - | (49) |
| Cash and cash equivalents | - | - | - | - | - | - |
| Net liabilities disposed | (6,857) | (1,079) | 180 | (410) | - | (8,166) |
| Currency translation reserve realised | 314 | (958) | (4,457) | 1,270 | 420 | (3,411) |
| Cash consideration received | - | - | - | - | - | - |
| Gain on disposal of subsidiaries | (6,543) | (2,037) | (4,277) | 860 | 420 | (11,577) |
| Cash consideration received | - | - | - | - | - | - |
| Net cash disposed with the subsidiary | - | - | - | - | - | - |
| Net cash flow on disposal | - | - | - | - | - | - |
The Group is currently considering several investment projects, focusing efforts, in particular, on herd rejuvenation. In 2021, the Group started the project to gradually renew its sow population in Ukraine to increase the birth rate of piglets. For this purpose, the Group is working with Genesus, a Canadian genetics company. During the nine months ended 30 September 2021, the Group already received the first batch of sows from Genesus.
Long-term investments of USD 2,445 thousand in the consolidated statement of financial position as at 30 September 2021, represent the initial project commitment funds allocated for these investment projects.
On 5 August 2021, KSG Agro S.A. received a formal notification from its immediate parent OLBIS Investments LTD. S.A. on the reduction in the number of shares OLBIS Investments LTD. S.A. holds in the Company by more than 1%.
The change in direct participation was a result of the sale of its 1 million shares in the Company on 2 August 2021. As at the date these financial statements are published, OLBIS Investments LTD. S.A. confirmed that the relevant share purchase agreements authorising the transfer of shares to the buyers have been signed.
Prior to the sale, OLBIS Investments LTD. S.A. held 9.7 million shares, which amounted to 64.62% of of the issued share capital. After the sale, OLBIS Investments LTD. S.A. holds 8.7 million shares, which is 57.96% of the issued share capital.
Buyers of the shares were parties not related to the Group.
As at the date these financial statements are authorised for issue, the Group finished harvesting sunflower and corn, and is now completing the sowing campaign for winter crops.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.